Pharmacogenetics.
D000700:Analgesics / Q000009:adverse effects; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000777:Anesthetics / Q000009:adverse effects; D001049:Apnea / Q000139:chemically induced; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D004357:Drug Synergism; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005334:Fever / Q000139:chemically induced; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D013390:Succinylcholine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D014427:Twins
D000700:Analgesics; D000777:Anesthetics; D004071:Digitalis Glycosides; D004364:Pharmaceutical Preparations; D013449:Sulfonamides; D010672:Phenytoin; D002701:Chloramphenicol; D013390:Succinylcholine; D007538:Isoniazid